MENU
HRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Heron Therapeutics (HRTX) Ownership - Who owns Heron Therapeutics?
Heron Therapeutics Inc is a commercial-stage biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
339.69M
P/E Ratio
N/A
Total Cash
59.28M
Projected Growth
N/A
Total Debt
177.76M
Revenue
144.29M
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
0.95 USD as % of share price
Fundamentals
HRTX
Capitalization
340M
P/E Ratio
N/A
Risk (Beta)
1.46
Dividend Yield
N/A
Total Cash
59.3M
Total Cash/Share
0.39
Total Debt
178M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.95%
Revenue
144M
ROE
N/A
Book Value
-33.65M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.52M
Current Ratio
2.29
Current Revenue Per Employee
334270.50
Dividends Per Share - Security
N/A
EBITDA
-5.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.92
Revenue To Assets
-5.96
Shares Held By Institutions
225M
Shares Outstanding - Current
152M
Total Liabilities
267M
Total Volume MTD
N/A
Value
-1
Gain YTD
45.752
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of polymer technologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com